Lymphoma
📧 Sign up to get email alerts when something new happens for Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-07-19Clinical Trial Update: Fenretinide in Treating Patients With Refractory or Relapsed Hematologic Cancer [Phase 1]
A Phase 1 trial of fenretinide in patients with refractory or relapsed hematologic cancers has been completed, investigating safety across m…
-
CLINICAL_TRIALS trial_result · 2017-07-17Clinical Trial Update: Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based Regimen [Phase 1, Phase 2]
A Phase 1/2 trial evaluating allogeneic hematopoietic cell transplantation using a busulfan-based conditioning regimen across multiple hemat…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: A Phase I Study of Vorinostat and Bortezomib in Children With Refractory of Recurrent Solid Tumors, Including CNS Tumors and Lymphomas [Phase 1]
This Phase I trial evaluated the combination of vorinostat and bortezomib in pediatric patients with refractory or recurrent solid tumors, i…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Evaluation of Late Treatment Effects in Long-Term Survivors of Hodgkin's Disease Previously Treated at NIH: A Multi-Institutional Trial
A completed multi-institutional NIH study evaluated late treatment effects in long-term survivors of Hodgkin lymphoma, investigating long-te…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: CDDO to Treat Solid Tumors and Lymphomas [Phase 1]
The National Cancer Institute-sponsored Phase 1 trial evaluated CDDO in patients with solid tumors and lymphoma; the study has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating busulfan, fludarabine, and total-body irradiation as conditioning for donor stem cell transplantation …
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: SNX-5422 to Treat Solid Tumor Cancers and Lymphomas [Phase 1]
Phase 1 trial results for SNX-5422 in solid tumors and lymphomas have completed.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Active Specific Immunotherapy for Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype Antigen Vaccines [Phase 1]
A Phase 1 trial evaluated a tumor-derived immunoglobulin idiotype antigen vaccine for follicular lymphoma. The trial status indicates comple…
-
CLINICAL_TRIALS withdrawal · 2017-07-02Clinical Trial Update: RO4929097 in Children With Relapsed/Refractory Solid or CNS Tumors, Lymphoma, or T-Cell Leukemia [Phase 1]
Phase 1 trial of RO4929097 in children with relapsed/refractory solid or CNS tumors, lymphoma, or T-cell leukemia has been withdrawn.
-
CLINICAL_TRIALS research · 2017-07-02Clinical Trial Update: Clinical, Laboratory and Epidemiologic Pilot Studies of Individuals at High Risk for Viral-Associated Cancers
This news update reports on completed pilot studies assessing clinical, laboratory, and epidemiologic aspects in people at high risk for vir…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Safety Study of ABT-888 Plus Topotecan Hydrochloride to Treat Patients With Solid Tumors and Lymphomas [Phase 1]
The document reports the completion of a Phase 1 safety study evaluating veliparib (ABT-888) in combination with topotecan hydrochloride for…
-
CLINICAL_TRIALS trial_result · 2017-06-28Clinical Trial Update: Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplant [Phase 2]
This Phase 2 trial evaluated sirolimus, tacrolimus, and antithymocyte globulin to prevent graft-versus-host disease in patients with hematol…
-
CLINICAL_TRIALS trial_result · 2017-06-28Clinical Trial Update: Rituximab and Combination Chemotherapy in Treating Patients With Primary Central Nervous System Lymphoma [Phase 2]
Phase 2 trial update evaluating rituximab with combination chemotherapy in primary central nervous system lymphoma; study terminated with re…
-
CLINICAL_TRIALS trial_result · 2017-06-27Clinical Trial Update: Simultaneous Care: Linking Palliation to Clinical Trials [NA]
This is a completed clinical trial update from the University of California, Davis about linking palliation to participation in clinical tri…
-
CLINICAL_TRIALS withdrawal · 2017-06-27Clinical Trial Update: Study of Pembrolizumab With Chemotherapy in Patients With Advanced Lymphoma (PembroHeme) [Phase 1, Phase 2]
The Phase 1/2 trial assessing pembrolizumab in combination with chemotherapy for advanced lymphoma has been withdrawn.
-
CLINICAL_TRIALS research · 2017-06-22Clinical Trial Update: Improving Patient Education for Lymphoma and Leukemia Inpatients [NA]
A completed clinical trial conducted by Emory University aimed at improving education for inpatients with leukemia or lymphoma.
-
CLINICAL_TRIALS trial_result · 2017-06-20Clinical Trial Update: A Study to Determine the Metabolism and Elimination of 14C-E7080 in Patients With Advanced Solid Tumors or Lymphomas, Who Are Unsuitable For, or Have Failed, Existing Therapies. [Phase 1]
Phase 1 study assessing how radiolabeled E7080 (lenvatinib) is metabolized and eliminated in patients with advanced solid tumors or lymphoma…
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematological Cancer or Other Disease [Phase 2]
Phase 2 trial update describing donor umbilical cord blood transplantation for advanced hematologic cancers, including leukemia, lymphoma, m…
-
CLINICAL_TRIALS withdrawal · 2017-06-12Clinical Trial Update: Intratumoral Dendritic Cell Vaccination Combined With Local Radiotherapy in Patients With Recurrent Lymphoma. [Phase 1, Phase 2]
A Phase 1/2 trial evaluated intratumoral dendritic cell vaccination combined with local radiotherapy in patients with recurrent lymphoma. Th…
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease [Phase 2]
Phase 2 trial evaluating reduced-intensity conditioning with busulfan and fludarabine, with or without antithymocyte globulin, followed by d…
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: T-Cell Depletion, Donor Hematopoietic Stem Cell Transplant (HSCT), and T-Cell Infusions in Treating Patients With Hematologic Cancer or Other Diseases [Phase 2]
Phase 2 study evaluating T-cell depletion and donor hematopoietic stem cell transplantation with T-cell infusions in patients with various h…
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Study of Nivolumab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) That Have Either Failed or Are Not Eligible for Autologous Stem Cell Transplant (CheckMate 139) [Phase 2]
Phase 2 trial evaluating nivolumab in relapsed or refractory diffuse large B-cell lymphoma (DLBCL) after autologous stem cell transplant fai…
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Music in Reducing Anxiety and Pain in Adult Patients Undergoing Bone Marrow Biopsy for Hematologic Cancers or Other Diseases [NA]
This ClinicalTrials.gov update reports on a completed study evaluating whether music can reduce anxiety and pain in adults undergoing bone m…
-
CLINICAL_TRIALS research · 2017-05-30Clinical Trial Update: Comparative Study of microRNA Changes in Patients With Reactive Lymphoid Hyperplasia and Malignant Lymphoma
This clinical trial update describes a comparative study of microRNA changes in patients with reactive lymphoid hyperplasia and malignant ly…
-
CLINICAL_TRIALS withdrawal · 2017-05-15Clinical Trial Update: Evaluation of a New EUS Guided Biopsy Needle (SharkCore) Comparing to Standard EUS Needle (ProCore) [Phase 2]
Phase 2 trial evaluating SharkCore EUS-guided biopsy needle versus ProCore has been withdrawn. Sponsor: Johns Hopkins University; conditions…